U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C27H33N2
Molecular Weight 385.5643
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 1

SHOW SMILES / InChI
Structure of BRILLIANT GREEN CATION

SMILES

CCN(CC)C1=CC=C(C=C1)C(C2=CC=CC=C2)=C3C=CC(C=C3)=[N+](CC)CC

InChI

InChIKey=HXCILVUBKWANLN-UHFFFAOYSA-N
InChI=1S/C27H33N2/c1-5-28(6-2)25-18-14-23(15-19-25)27(22-12-10-9-11-13-22)24-16-20-26(21-17-24)29(7-3)8-4/h9-21H,5-8H2,1-4H3/q+1

HIDE SMILES / InChI

Molecular Formula C27H33N2
Molecular Weight 385.5643
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Brilliant green is a synthetic dye. Brilliant green inhibits the growth of gram-positive bacterias and thus has antibacterial properties. It is broadly used as a topical antiseptic (in form of cutaneous solution), especially in Russia and Eastern Europe.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Preventing
BRILLIANT GREEN

Approved Use

Brilliant green is used as antiseptic for skin abrasions and scratches; to mark the intended section place before the surgical operation.
Preventing
KERR 100 TRIPLE DYE

Approved Use

Aids in the prevention of infection in the umbilical cord area of newborn.
PubMed

PubMed

TitleDatePubMed
Profiling of a prescription drug library for potential renal drug-drug interactions mediated by the organic cation transporter 2.
2011-07-14
Effect of brilliant green on the motility of Salmonellae and other selected microorganisms.
1969-10
EFFECT OF VARIOUS CONCENTRATIONS OF BRILLIANT GREEN AND BILE SALTS ON SALMONELLAE AND OTHER MICROORGANISMS.
1965-01
Use of crystal violet or brilliant green dyes for the determination of Salmonellae in dried food products.
1960-12
A Note on the Value of Brilliant Green as an Antiseptic.
1917-06-30
Patents

Sample Use Guides

Apply to the affected area using cotton swabs or gauze pads.
Route of Administration: Topical
Staphylococcus aureus strain was treated with brilliant green at final concentration of 8.8*10(-4) M. At this concentration the drug inhibited the cells growth by 50%.
Substance Class Chemical
Created
by admin
on Mon Mar 31 20:56:12 GMT 2025
Edited
by admin
on Mon Mar 31 20:56:12 GMT 2025
Record UNII
S85JD8CLBH
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BRILLIANT GREEN ION
Preferred Name English
BRILLIANT GREEN CATION
Common Name English
ETHANAMINIUM, N-(4-((4-(DIETHYLAMINO)PHENYL)PHENYLMETHYLENE)-2,5-CYCLOHEXADIEN-1-YLIDENE)-N-ETHYL-
Systematic Name English
BRILLIANT GREEN, FREE FORM
Common Name English
Code System Code Type Description
DAILYMED
S85JD8CLBH
Created by admin on Mon Mar 31 20:56:12 GMT 2025 , Edited by admin on Mon Mar 31 20:56:12 GMT 2025
PRIMARY
ECHA (EC/EINECS)
242-088-5
Created by admin on Mon Mar 31 20:56:12 GMT 2025 , Edited by admin on Mon Mar 31 20:56:12 GMT 2025
PRIMARY
RXCUI
1546367
Created by admin on Mon Mar 31 20:56:12 GMT 2025 , Edited by admin on Mon Mar 31 20:56:12 GMT 2025
PRIMARY RxNorm
FDA UNII
S85JD8CLBH
Created by admin on Mon Mar 31 20:56:12 GMT 2025 , Edited by admin on Mon Mar 31 20:56:12 GMT 2025
PRIMARY
PUBCHEM
12450
Created by admin on Mon Mar 31 20:56:12 GMT 2025 , Edited by admin on Mon Mar 31 20:56:12 GMT 2025
PRIMARY
DRUG BANK
DB11279
Created by admin on Mon Mar 31 20:56:12 GMT 2025 , Edited by admin on Mon Mar 31 20:56:12 GMT 2025
PRIMARY
EPA CompTox
DTXSID40171223
Created by admin on Mon Mar 31 20:56:12 GMT 2025 , Edited by admin on Mon Mar 31 20:56:12 GMT 2025
PRIMARY
CAS
18198-35-1
Created by admin on Mon Mar 31 20:56:12 GMT 2025 , Edited by admin on Mon Mar 31 20:56:12 GMT 2025
PRIMARY
Related Record Type Details
ACTIVE MOIETY